WKN: | 904278 |
ISIN: | CH0012005267 |
Land: | Schweiz |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Novartis-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 29. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 1997 | 18,15 | 31,90 | 75,74% |
2 | 1995 | 8,49 | 13,93 | 64,16% |
3 | 1991 | 3,44 | 5,09 | 48,14% |
4 | 1993 | 6,91 | 10,09 | 45,98% |
5 | 1992 | 5,09 | 6,91 | 35,78% |
6 | 2000 | 31,20 | 41,62 | 33,39% |
7 | 2014 | 51,36 | 67,90 | 32,20% |
8 | 1996 | 13,93 | 18,15 | 30,30% |
9 | 2019 | 65,93 | 84,54 | 28,24% |
10 | 2013 | 42,08 | 51,36 | 22,04% |
11 | 2005 | 32,77 | 39,26 | 19,81% |
12 | 2025 | 94,52 | 109,06 | 15,38% |
13 | 2010 | 33,68 | 38,85 | 15,35% |
14 | 1998 | 31,90 | 35,85 | 12,37% |
15 | 2022 | 77,48 | 84,66 | 9,26% |
16 | 2023 | 84,66 | 91,28 | 7,83% |
17 | 2012 | 39,11 | 42,08 | 7,60% |
18 | 2009 | 31,49 | 33,68 | 6,96% |
19 | 2018 | 62,25 | 65,93 | 5,90% |
20 | 2015 | 67,90 | 70,56 | 3,92% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 1994 | 10,09 | 8,49 | -15,89% |
2 | 2002 | 35,88 | 30,74 | -14,32% |
3 | 2007 | 38,58 | 33,17 | -14,03% |
4 | 2001 | 41,62 | 35,88 | -13,79% |
5 | 2016 | 70,56 | 61,10 | -13,40% |
6 | 1999 | 35,85 | 31,20 | -12,96% |
7 | 2020 | 84,54 | 77,34 | -8,52% |
8 | 2008 | 33,17 | 31,49 | -5,07% |
9 | 2006 | 39,26 | 38,58 | -1,74% |
10 | 2021 | 77,34 | 77,48 | 0,18% |
11 | 2011 | 38,85 | 39,11 | 0,67% |
12 | 2017 | 61,10 | 62,25 | 1,88% |
13 | 2004 | 31,82 | 32,77 | 3,00% |
14 | 2003 | 30,74 | 31,82 | 3,51% |
15 | 2024 | 91,28 | 94,52 | 3,55% |
16 | 2015 | 67,90 | 70,56 | 3,92% |
17 | 2018 | 62,25 | 65,93 | 5,90% |
18 | 2009 | 31,49 | 33,68 | 6,96% |
19 | 2012 | 39,11 | 42,08 | 7,60% |
20 | 2023 | 84,66 | 91,28 | 7,83% |